• Emil Pot, Co-Founder and CEO of Allero Therapeutics

  • Oct 20 2021
  • Durée: 49 min
  • Podcast

Emil Pot, Co-Founder and CEO of Allero Therapeutics

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • As something that affects as much as 10% of the global population, food allergies are an important topic of discussion in this value-packed episode of High Potential Start-ups.

    In episode 3, guest speaker Emil Pot, Co-Founder and CEO of Allero Therapeutics, and host Nick Ross, Co-Founder of Cavenagh Health, delve into numerous talking points surrounding everything from food-related immune disorders to running a successful biotech company. 

    Emil’s career started in law, but his keen interest in science quickly led to biotech becoming the central point of his career.

    Now, Emil and his team at Allero Therapeutics have developed an innovative solution to treating autoimmune disorders like celiac disease.

    Get in touch with Emil.

    Get in Touch with Nick.
    Voir plus Voir moins
Voir plus Voir moins
activate_Holiday_promo_in_buybox_DT_T2

Ce que les auditeurs disent de Emil Pot, Co-Founder and CEO of Allero Therapeutics

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.